Online car dealership service ACV Auctions has filed to go public having previously raised some $360m in funding from investors including SoftBank.

Osage University Partners has thrown its weight behind a series A2 round for Artizan, which is advancing work undertaken at Yale University.

Biohaven Therapeutics co-led Artizan Biosciences' latest round as part of an option and licensing agreement focusing on its inflammatory bowel disease drug candidates.

Xenotransplantation technology developer eGenesis has raised $125m in a series C round backed by Osage University Partners.

An unnamed casino operator invested in the sports and esports betting platform developer in around that will support international expansion.

Reliance paid $26.8m to gain majority control of the passive magnetic levitation and propulsion technology developer and now owns 54.5% of its shares.

Citi's Impact Fund and Mastercard were among the investors as the mobile banking software provider secured $12m in series A funding.

SoftBank is the largest investor in the online real estate portal, which was valued at $6.4bn in its series G round early last year.

Access Industries is set to exit the cloud infrastructure technology developer, which has filed to raise up to $100m on the New York Stock Exchange.

GV returned to help heart disease drug developer Tenaya boost its overall funding to approximately $248m.